Nong Yang

机构：Central South University, Second People Hospital of Hunan, Hunan Cancer Hospital · ORCID：0000-0003-0997-3645

发表论文 253 篇 · 总被引 7456 次 · h-index 39

代表论文

• Overall survival according to time-of-day of combined immuno-chemotherapy for advanced non-small cell lung cancer: a bicentric bicontinental study (2025 · EBioMedicine · 被引 47)
• RETRACTED: Randomized trial of relevance of time-of-day of immunochemotherapy for progression-free and overall survival in patients with non-small cell lung cancer. (2025 · Journal of Clinical Oncology · 被引 13)
• Savolitinib (Savo) combined with osimertinib (osi) versus chemotherapy (chemo) in EGFR-mutant (EGFRm) and MET -amplification ( MET amp) advanced NSCLC after disease progression (PD) on EGFR tyrosine kinase inhibitor (TKI): Results from a randomized phase 3 SACHI study. (2025 · Journal of Clinical Oncology · 被引 9)
• Toripalimab plus platinum-doublet chemotherapy as perioperative therapy for initially unresectable NSCLC: An open-label, phase 2 trial (2025 · Med · 被引 9)
• A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001) (2025 · Journal of Hematology & Oncology · 被引 9)
• Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration (2025 · Cancer Biology and Medicine · 被引 7)